Literature DB >> 12044411

Predicting the failure of amyloid-beta vaccine.

Mark A Smith, Craig S Atwood, James A Joseph, George Perry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12044411     DOI： 10.1016/S0140-6736(02)08695-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose!

Authors:  Hyoung-gon Lee; Xiongwei Zhu; Akihiko Nunomura; George Perry; Mark A Smith
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 2.  Treating the lesions, not the disease.

Authors:  Xiongwei Zhu; Jesus Avila; George Perry; Mark A Smith
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

3.  The fallacy of amyloid and cognition in Alzheimer's disease.

Authors:  Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  The end of Alzheimer's disease--from biochemical pharmacology to ecopsychosociology: a personal perspective.

Authors:  Peter J Whitehouse
Journal:  Biochem Pharmacol       Date:  2013-12-01       Impact factor: 5.858

5.  Pathology's new role: defining disease process and protective responses.

Authors:  George Perry; Rudy J Castellani; Paula I Moreira; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 6.  Novel therapeutics for Alzheimer's disease: an update.

Authors:  David J Bonda; Hyun-Pil Lee; Hyoung-gon Lee; Avi L Friedlich; George Perry; Xiongwei Zhu; Mark A Smith
Journal:  Curr Opin Drug Discov Devel       Date:  2010-03

7.  Frontiers in Alzheimer's disease therapeutics.

Authors:  Jeremy G Stone; Gemma Casadesus; Kasia Gustaw-Rothenberg; Sandra L Siedlak; Xinglong Wang; Xiongwei Zhu; George Perry; Rudy J Castellani; Mark A Smith
Journal:  Ther Adv Chronic Dis       Date:  2011-01-01       Impact factor: 5.091

Review 8.  Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?

Authors:  Hyoung-Gon Lee; Rudy J Castellani; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Int J Exp Pathol       Date:  2005-06       Impact factor: 1.925

9.  Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders.

Authors:  R Lee Mosley; Howard E Gendelman
Journal:  Exp Neurol       Date:  2010-01-04       Impact factor: 5.330

Review 10.  Iron: the Redox-active center of oxidative stress in Alzheimer disease.

Authors:  Rudy J Castellani; Paula I Moreira; Gang Liu; Jon Dobson; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  Neurochem Res       Date:  2007-05-17       Impact factor: 3.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.